Photocure ASA, Iyo Bladder Cancer Company, yakazivisa kuti US Chikafu neDrug Administration (FDA) yakabvumidza itsva uye yakagadziridzwa Blue Light sisitimu kuti ishandiswe nePhotocure's Cysview® chigadzirwa muBlue Light Cystoscopy (BLC®) maitiro ekuonekwa kweNMIBC. *. Yakagadzirwa uye ichakurumidza kutengeswa neKARL STORZ Endoscopy-America, Inc. (KARL STORZ), iyo itsva Blue Light system inotenderwa kuti ishandiswe mumaitiro anoda rigid cystoscopy. Mvumo yeFDA yakapihwa KARL STORZ muna Kukadzi 4, 2022.
"Kutenderwa kwakabudirira kweFDA inhau huru kunharaunda yegomarara redundiro muUS," akadaro Geoffrey Coy, Mutevedzeri weMutungamiriri uye General Manager, North America kuPhotocure. "Pahutano hwehutano, hunyanzvi hwekuvandudza tekinoroji hwakakosha, uye tinotarisira kuti iyi itsva, yakagadziridzwa BLC system ichazadzisa tarisiro yevatengi vedu yekuvandudza ruzivo rweBlue Light. Iyo itsva sisitimu chizvarwa chinotevera uye inosanganisira inoshanda maficha kuita kuti tekinoroji iwedzere mushandisi. Tinotarisira kuwedzera kushandiswa kweBLC neCysview®, "Geoffrey Coy akapedzisa.
"PaKARL STORZ, takazvipira kubatsira vatengi vedu kuendesa kutarisirwa kwemhando yepamusoro, uye tinotenda kuti hurongwa hwedu hutsva hweBlue Light hunoratidza kuzvipira uku," akadaro Michael Lyman, Executive Director, Sales & Marketing, Urology uye Gynecology, KARL STORZ Endoscopy. -America. "The New Blue Light Powered by Saphira® ichatibvumira kushanda zvinodiwa nevatengi vedu, ichipa inotevera-nhanho yekuona kuti igone kugonesa mhinduro dzeurological maitiro muvarwere vane Non-Muscle Invasive Bladder Cancer uye kuenderera mberi nekubatana kwedu nechikwata chePhotocure. kuita kuti yemhando yepamusoro BLC iwanikwe kune vamwe varwere muUS ”.
Photocure inotarisira kuzivisa vanobata vayo nezvekutanga kweiyo Blue Light system sezvo KARL STORZ ichipa rumwe ruzivo nezve chigadzirwa uye hurongwa hwekutanga.
ZVOKUBVA MUNYAYA INO:
- “The New Blue Light Powered by Saphira® will allow us to serve the needs of our customers, providing next-level visualization to enable the right solutions for urological procedures in patients with Non-Muscle Invasive Bladder Cancer and continue our collaboration with the Photocure team to make high-quality BLC available to more patients in the U.
- Food and Drug Administration (FDA) approved of a new and improved Blue Light system to be used with Photocure’s Cysview® product in Blue Light Cystoscopy (BLC®) procedures for the detection of NMIBC*.
- Photocure inotarisira kuzivisa vanobata vayo nezvekutanga kweiyo Blue Light system sezvo KARL STORZ ichipa rumwe ruzivo nezve chigadzirwa uye hurongwa hwekutanga.
